A23V2250/186

PUFA SALT FORMULATIONS (I)

The present patent application relates to novel polyunsaturated fatty acid salt (PUFA salts) solid formulations.

PUFA SALT FORMULATIONS (I)

The present patent application relates to novel polyunsaturated fatty acid salt (PUFA salts) solid formulations.

FOOD PRODUCT OR BEVERAGE CONTAINING A MARINE MICROALGA
20200037649 · 2020-02-06 ·

The subject of the invention is a product for human or animal consumption, in the form of food or drink, comprising between 0.2 and 50% by weight of biomass of a marine microalga and/or at least one extract of said microalga. The invention also relates to the use of this marine microalga and/or at least one extract of said microalga as a flavor booster and/or enhancer in food products or beverages.

FOOD PRODUCT OR BEVERAGE CONTAINING A MARINE MICROALGA
20200037649 · 2020-02-06 ·

The subject of the invention is a product for human or animal consumption, in the form of food or drink, comprising between 0.2 and 50% by weight of biomass of a marine microalga and/or at least one extract of said microalga. The invention also relates to the use of this marine microalga and/or at least one extract of said microalga as a flavor booster and/or enhancer in food products or beverages.

Flavor Modifiers For Meat Analog Products

A flavor modifier composition for a meat analog is provided. The flavor modifier composition includes a yeast extract; a fatty acid; peptide material having a molecular weight of from about 300 to about 10,000 daltons; and at least two free amino acids wherein at least one free amino acid is a sulfur containing amino acid.

Flavor Modifiers For Meat Analog Products

A flavor modifier composition for a meat analog is provided. The flavor modifier composition includes a yeast extract; a fatty acid; peptide material having a molecular weight of from about 300 to about 10,000 daltons; and at least two free amino acids wherein at least one free amino acid is a sulfur containing amino acid.

Plant extract compositions and methods of preparation thereof

Embodiments described herein relate generally to plant extract compositions and methods to isolate cutin-derived monomers, oligomers, and mixtures thereof for application in agricultural coating formulations, and in particular, to methods of preparing plant extract compositions that include functionalized and non-functionalized fatty acids and fatty esters (as well as their oligomers and mixtures thereof), which are substantially free from accompanying plant-derived compounds (e.g., proteins, polysaccharides, phenols, lignans, aromatic acids, terpenoids, flavonoids, carotenoids, alkaloids, alcohols, alkanes, and aldehydes) and can be used in agricultural coating formulations.

Plant extract compositions and methods of preparation thereof

Embodiments described herein relate generally to plant extract compositions and methods to isolate cutin-derived monomers, oligomers, and mixtures thereof for application in agricultural coating formulations, and in particular, to methods of preparing plant extract compositions that include functionalized and non-functionalized fatty acids and fatty esters (as well as their oligomers and mixtures thereof), which are substantially free from accompanying plant-derived compounds (e.g., proteins, polysaccharides, phenols, lignans, aromatic acids, terpenoids, flavonoids, carotenoids, alkaloids, alcohols, alkanes, and aldehydes) and can be used in agricultural coating formulations.

Nutritional composition and infant formula for promoting myelination of the brain

A synthetic nutritional composition comprising a fatty acid derivative for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.

Nutritional composition and infant formula for promoting myelination of the brain

A synthetic nutritional composition comprising a fatty acid derivative for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.